Abstract:During the past two decades effective drugs for treating osteoporosis have been developed, including anti-resorptives inhibiting bone resorption (estrogens, the SERM raloxifene, four bisphosphonates, RANKL inhibitor denosumab) and the anabolic bone forming daily injectable peptide teriparatide. Two potential drugs (odanacatib and romosozumab) are in late stage clinical development. The most pressing unmet need is for orally active anabolic drugs. This review describes the basic biological studies involved in developing these drugs, including the animal models employed for osteoporosis drug development. The genomics revolution continues to identify potential novel osteoporosis drug targets. Studies include human GWAS studies and identification of mutant genes in subjects having abnormal bone mass, mouse QTL and gene knockouts, and gene expression studies. Multiple lines of evidence indicate that Wnt signaling plays a major role in regulating bone formation and continued study of this complex pathway is likely to lead to key discoveries. In addition to the classic Wnt signaling targets DKK1 and sclerostin, LRP4, LRP5/LRP6, SFRP4, WNT16, and NOTUM can potentially be targeted to modulate Wnt signaling. Next-generation whole genome and exome sequencing, RNA-sequencing and CRISPR/CAS9 gene editing are new experimental techniques contributing to understanding the genome. The International Knockout Mouse Consortium efforts to knockout and phenotype all mouse genes are poised to accelerate. Accumulating knowledge will focus attention on readily accessible databases (Big Data). Efforts are underway by the International Bone and Mineral Society to develop an annotated Skeletome database providing information on all genes directly influencing bone mass, architecture, mineralization or strength.

Osteoporosis: mechanism, molecular target and current status on drug development

Research and Application of Target Therapy for Osteoporosis

Osteoporosis treatment: current drugs and future developments

Advances in Pathogenesis and Therapeutic Strategies for Osteoporosis

Recent Progresses in the Treatment of Osteoporosis

Emerging Therapeutic Targets for Osteoporosis Treatment.

Molecular Mechanisms and Emerging Therapeutics for Osteoporosis

Recent advance of small-molecule drugs for clinical treatment of osteoporosis: A review

Progress in Anti-Osteoporosis Drug Treatment

Mechanistic Advances in Osteoporosis and Anti-Osteoporosis Therapies.

Genetic Approaches To Identifying Novel Osteoporosis Drug Targets

Mechanistic Insights and Therapeutic Strategies in Osteoporosis: A Comprehensive Review

Research progress on drugs in osteoporosis therapy

Cellular Communication in Bone Homeostasis and the Related Anti-osteoporotic Drug Development

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis

Mechanisms of Bone Anabolism Regulated by Statins

Osteoporosis therapies and their mechanisms of action (Review)

Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review

Synthesis and biological activities of drugs for the treatment of osteoporosis

Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions

Drug Delivery and Therapy Strategies for Osteoporosis Intervention